botox

Generic: onabotulinumtoxina

Labeler: allergan, inc.
NDC Directory HUMAN PRESCRIPTION DRUG BLA Inactive Finished

Drug Facts

Product Profile

Brand Name botox
Generic Name onabotulinumtoxina
Labeler allergan, inc.
Dosage Form INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
Routes
INTRADERMAL INTRAMUSCULAR
Active Ingredients

botulinum toxin type a 100 [USP'U]/1

Manufacturer
Allergan, Inc.

Identifiers & Regulatory

Product NDC 0023-1145
Product ID 0023-1145_7365af65-15e0-4fc1-aa6a-aaec5a43c468
Product Type HUMAN PRESCRIPTION DRUG
Marketing Category BLA
Application Number BLA103000
Listing Expiration 2026-12-31
Marketing Start 1989-12-15

Pharmacologic Class

Established (EPC)
acetylcholine release inhibitor [epc] neuromuscular blocker [epc]
Mechanism of Action
acetylcholine release inhibitors [moa]
Physiologic Effect
neuromuscular blockade [pe]

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 00231145
Hyphenated Format 0023-1145

Supplemental Identifiers

RxCUI
860192 860195 897366 897368
UNII
E211KPY694
NUI
N0000175771 N0000193962 N0000175731 N0000175770

Packaging Origin

Original Packager
true

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name botox (source: ndc)
Generic Name onabotulinumtoxina (source: ndc)
Application Number BLA103000 (source: ndc)
Routes
INTRADERMAL INTRAMUSCULAR
source: ndc

Resolved Composition

Strengths
  • 100 [USP'U]/1
source: ndc
Packaging
  • 1 VIAL in 1 CARTON (0023-1145-01) / 1 INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION in 1 VIAL
  • 1 VIAL in 1 CARTON (0023-1145-02) / 1 INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION in 1 VIAL
source: ndc

Packages (2)

0023-1145-01 1 VIAL in 1 CARTON (0023-1145-01) / 1 INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION in 1 VIAL 0023-1145-02 1 VIAL in 1 CARTON (0023-1145-02) / 1 INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION in 1 VIAL

Ingredients (1)

botulinum toxin type a (100 [USP'U]/1)

Linked Drug Pages (1)

BOTOX ndc-match (0.9)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["INTRADERMAL", "INTRAMUSCULAR"], "spl_id": "7365af65-15e0-4fc1-aa6a-aaec5a43c468", "openfda": {"nui": ["N0000175771", "N0000193962", "N0000175731", "N0000175770"], "unii": ["E211KPY694"], "rxcui": ["860192", "860195", "897366", "897368"], "spl_set_id": ["33d066a9-34ff-4a1a-b38b-d10983df3300"], "pharm_class_pe": ["Neuromuscular Blockade [PE]"], "pharm_class_epc": ["Acetylcholine Release Inhibitor [EPC]", "Neuromuscular Blocker [EPC]"], "pharm_class_moa": ["Acetylcholine Release Inhibitors [MoA]"], "manufacturer_name": ["Allergan, Inc."], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "1 VIAL in 1 CARTON (0023-1145-01)  / 1 INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION in 1 VIAL", "package_ndc": "0023-1145-01", "marketing_start_date": "19891215"}, {"sample": false, "description": "1 VIAL in 1 CARTON (0023-1145-02)  / 1 INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION in 1 VIAL", "package_ndc": "0023-1145-02", "marketing_start_date": "19891215"}], "brand_name": "BOTOX", "product_id": "0023-1145_7365af65-15e0-4fc1-aa6a-aaec5a43c468", "dosage_form": "INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION", "pharm_class": ["Acetylcholine Release Inhibitor [EPC]", "Acetylcholine Release Inhibitors [MoA]", "Neuromuscular Blockade [PE]", "Neuromuscular Blocker [EPC]"], "product_ndc": "0023-1145", "generic_name": "onabotulinumtoxinA", "labeler_name": "Allergan, Inc.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "BOTOX", "active_ingredients": [{"name": "BOTULINUM TOXIN TYPE A", "strength": "100 [USP'U]/1"}], "application_number": "BLA103000", "marketing_category": "BLA", "marketing_start_date": "19891215", "listing_expiration_date": "20261231"}